XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating expenses    
Research and development $ 16,977 $ 6,334
General and administrative 11,556 6,033
Total operating expenses 28,533 12,367
Financing (income) expenses, net (353) 111
Loss before taxes 28,180 12,478
Taxes on income (benefit) (534) 0
Net loss for the year $ 27,646 $ 12,478
Basic loss per Ordinary Share $ 0.121 $ 0.06
Diluted loss per Ordinary Share $ 0.121 $ 0.06
Weighted average number of Ordinary Shares outstanding, basic 227,589,288 207,468,650
Weighted average number of Ordinary Shares outstanding, diluted 227,589,288 207,468,650